The Nasdaq Biotechnology Index rose by 1.55%. Among the constituent stocks, Akero Therapeutics increased by 22.71%, Sana Biotechnology rose by 22.02%, and 89bio climbed by 20.97%. COVID-19 vaccine concept stock CureVac NV ADR rose by 10.47%, while Moderna increased by 6.31%. In contrast, Anavex Life Sciences fell by 9.95%, Prime Medicine dropped by 15.01%, and Alumis decreased by 16.89%

The Nasdaq Biotechnology Index closed up 1.55%. Component stock Akero Therapeutics rose 22.71%, Sana Biotechnology rose 22.02%, and 89bio rose 20.97%, ranking third. COVID-19 vaccine concept stocks CureVac NV ADR rose 10.47% and Moderna rose 6.31%, performing well. Anavex Life Sciences fell 9.95%, ranking third from the bottom, Prime Medicine fell 15.01%, and Alumis fell 16.89%